A phase 2 study of the therapeutic vaccine is currently underway in other centers in patients with recurrent disease to see if it can help extend 12 - month survival. (jagwire.augusta.edu)
The final chapter provides contemporary guidelines for the initial management of ovarian cancer as well as for recurrent disease. (future-science-group.com)
Additionally, the treatment - free interval steadily decreased for patients diagnosed with recurrent disease and treated with multiple rounds of chemotherapy. (sciencedaily.com)